SARM1 promotes neuroinflammation and inhibits neural regeneration after spinal cord injury through NF-κB signaling
Huitao Liu,Jingjing Zhang,Xingxing Xu,Sheng Lu,Danlu Yang,Changnan Xie,Mengxian Jia,Wenbin Zhang,Lingting Jin,Xiwu Wang,Xiya Shen,Fayi Li,Wangfei Wang,Xiaomei Bao,Sijia Li,Minyu Zhu,Wei Wang,Ying Wang,Zhihui Huang,Honglin Teng
DOI: https://doi.org/10.7150/thno.49054
IF: 11.6
2021-01-01
Theranostics
Abstract:<p>Axonal degeneration is a common pathological feature in many acute and chronic neurological diseases such as spinal cord injury (SCI). SARM1 (sterile alpha and TIR motif-containing 1), the fifth TLR (Toll-like receptor) adaptor, has diverse functions in the immune and nervous systems, and recently has been identified as a key mediator of Wallerian degeneration (WD). However, the detailed functions of SARM1 after SCI still remain unclear.</p><p><b>Methods:</b> Modified Allen's method was used to establish a contusion model of SCI in mice. Furthermore, to address the function of SARM1 after SCI, conditional knockout (CKO) mice in the central nervous system (CNS), SARM1<sup>Nestin</sup>-CKO mice, and SARM1<sup>GFAP</sup>-CKO mice were successfully generated by Nestin-Cre and GFAP-Cre transgenic mice crossed with SARM1<sup>flox/flox</sup> mice, respectively. Immunostaining, Hematoxylin-Eosin (HE) staining, Nissl staining and behavioral test assays such as footprint and Basso Mouse Scale (BMS) scoring were used to examine the roles of SARM1 pathway in SCI based on these conditional knockout mice. Drugs such as FK866, an inhibitor of SARM1, and apoptozole, an inhibitor of heat shock protein 70 (HSP70), were used to further explore the molecular mechanism of SARM1 in neural regeneration after SCI.</p><p><b>Results:</b> We found that SARM1 was upregulated in neurons and astrocytes at early stage after SCI. SARM1<sup>Nestin</sup>-CKO and SARM1<sup>GFAP</sup>-CKO mice displayed normal development of the spinal cords and motor function. Interestingly, conditional deletion of SARM1 in neurons and astrocytes promoted the functional recovery of behavior performance after SCI. Mechanistically, conditional deletion of SARM1 in neurons and astrocytes promoted neuronal regeneration at intermediate phase after SCI, and reduced neuroinflammation at SCI early phase through downregulation of NF-κB signaling after SCI, which may be due to upregulation of HSP70. Finally, FK866, an inhibitor of SARM1, reduced the neuroinflammation and promoted the neuronal regeneration after SCI.</p><p><b>Conclusion:</b> Our results indicate that SARM1-mediated prodegenerative pathway and neuroinflammation promotes the pathological progress of SCI and anti-SARM1 therapeutics are viable and promising approaches for preserving neuronal function after SCI.</p>
medicine, research & experimental